Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms - Atyeo, Caroline G.; Shook, Lydia L.; Brigida, Sara; De Guzman, Rose M.; Demidkin, Stepan; Muir, Cordelia; Akinwunmi, Babatunde; Baez, Arantxa Medina; Sheehan, Maegan L.; McSweeney, Erin; Burns, Madeleine D.; Nayak, Ruhi; et al. (Nature communications, 2022)
Keywords: 13/1; 13/31; 631/250/2152/2153/1291; 631/250/590; 631/326/596/4130; Ad26COVS1; Antibodies; Antibodies, Viral; Antibody response; BNT162 Vaccine; Cell activation; Complement activation; Cord blood; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines; Fc receptors; Female; Humanities and Social Sciences; Humans; Immune response; Immune response (humoral); Immune system; Immunity; Infant, Newborn; Leukocytes (neutrophilic); Morbidity; mRNA; multidisciplinary; Neonates; Phagocytosis; Placenta; Platforms; Pregnancy; Pregnancy Complications, Infectious - prevention & control; SARS-CoV-2; Science; Science (multidisciplinary); Serology; Severe acute respiratory syndrome coronavirus 2; Umbilical cord; United States; Vaccination - methods; Vaccines; United States